Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $227.4 million.

  • Gossamer Bio's Shares Outstanding (Weighted Average) rose 0.51% to $227.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.4 million, marking a year-over-year increase of 0.51%. This contributed to the annual value of $226.6 million for FY2024, which is 0.53% up from last year.
  • Per Gossamer Bio's latest filing, its Shares Outstanding (Weighted Average) stood at $227.4 million for Q3 2025, which was up 0.03% from $227.3 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Shares Outstanding (Weighted Average) peaked at $227.4 million during Q3 2025, and registered a low of $76.5 million during Q1 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $226.2 million (2024), whereas its average is $202.5 million.
  • Data for Gossamer Bio's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 139.82% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Gossamer Bio's Shares Outstanding (Weighted Average) stood at $94.5 million in 2022, then skyrocketed by 138.59% to $225.4 million in 2023, then rose by 0.53% to $226.6 million in 2024, then climbed by 0.51% to $227.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $227.4 million for Q3 2025, versus $227.3 million for Q2 2025 and $227.2 million for Q1 2025.